Cancer research at the University of Southampton ranges from basic cellular and molecular biology right through to the epidemiology of service provision. Major strengths include basic and translational immunology and tumour survival in lymphoma and solid tumours.
Southampton also hosts a centre of excellence in Leukaemia and Lymphoma Researchwhere it specialises in understanding and treating chronic lymphocytic leukaemia.
Our aim is to foster high quality cancer research with a particular emphasis on translating mechanistic understanding into patient treatments. We concentrate upon our research strengths, such as immunology and cell biology closely allied to clinical practice in cancer treatment. The Cancer Sciences School will shortly open a new purpose-built Cancer Immunology Centre to expand research capacity and accelerate our translation of immunotherapy to patients. This Centre will provide dedicated state of the art laboratory facilities to house over 200 scientists and support staff, comprising both basic discovery science and clinical teams. It will focus on all aspects of cancer immunology and immunotherapy from the bench to the patient.
All cancer research has clinical application as its ultimate goal. Our Cancer Sciences research is conducted on the Biomedical Campus at Southampton General Hospital, in purpose-built laboratories in the Somers Building and neighbouring laboratories.
We have more than 100 researchers, clinicians and associated staff working as coordinated teams across several disciplines. We bring ideas and discoveries made in the laboratory into clinical practice as rapidly as possible and ensure that the scientific hypotheses underlying cancer treatments are fully tested.
The University of Southampton Clinical Trials Unit is also supported by funding from Cancer Research UK to deliver large multicentre cancer treatment trials.
Contact us
Committee members; Dr Gessa Sugiyarto, Dr Kirstie Cleary, Dr Robert Oldham, Dr Emma Sparrow and Ms Cindy Jawahar